These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9155092

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists.
    Guarnieri F.
    Vitam Horm; 2017; 105():19-37. PubMed ID: 28629518
    [Abstract] [Full Text] [Related]

  • 5. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
    Schimmenti LA, Blechert G, Harris KW, Winkelmann JC.
    Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Physical and functional interaction between p72(syk) and erythropoietin receptor.
    Duprez V, Blank U, Chrétien S, Gisselbrecht S, Mayeux P.
    J Biol Chem; 1998 Dec 18; 273(51):33985-90. PubMed ID: 9852052
    [Abstract] [Full Text] [Related]

  • 8. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction.
    Philo JS, Aoki KH, Arakawa T, Narhi LO, Wen J.
    Biochemistry; 1996 Feb 06; 35(5):1681-91. PubMed ID: 8634300
    [Abstract] [Full Text] [Related]

  • 9. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.
    Middleton SA, Barbone FP, Johnson DL, Thurmond RL, You Y, McMahon FJ, Jin R, Livnah O, Tullai J, Farrell FX, Goldsmith MA, Wilson IA, Jolliffe LK.
    J Biol Chem; 1999 May 14; 274(20):14163-9. PubMed ID: 10318834
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythropoietin and co.: intrinsic structure and functional disorder.
    Uversky VN, Redwan EM.
    Mol Biosyst; 2016 Dec 20; 13(1):56-72. PubMed ID: 27833947
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor.
    Nagao M, Masuda S, Abe S, Ueda M, Sasaki R.
    Biochem Biophys Res Commun; 1992 Oct 30; 188(2):888-97. PubMed ID: 1445329
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activation of erythropoietin signaling by receptor dimerization.
    Watowich SS.
    Int J Biochem Cell Biol; 1999 Oct 30; 31(10):1075-88. PubMed ID: 10582340
    [Abstract] [Full Text] [Related]

  • 18. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.
    Livnah O, Johnson DL, Stura EA, Farrell FX, Barbone FP, You Y, Liu KD, Goldsmith MA, He W, Krause CD, Pestka S, Jolliffe LK, Wilson IA.
    Nat Struct Biol; 1998 Nov 30; 5(11):993-1004. PubMed ID: 9808045
    [Abstract] [Full Text] [Related]

  • 19. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.
    Watowich SS, Hilton DJ, Lodish HF.
    Mol Cell Biol; 1994 Jun 30; 14(6):3535-49. PubMed ID: 8196600
    [Abstract] [Full Text] [Related]

  • 20. The human erythropoietin receptor.
    Winkelmann JC.
    Int J Cell Cloning; 1992 Sep 30; 10(5):254-61. PubMed ID: 1453011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.